微RNA-1在急性肺损伤时保护内皮
Asawari Korde1, Maria Haslip1, Prachi Pednekar2
1Department of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
JCI insight
|September 22, 2023
概括
微RNA-1 (miR-1) 通过保持内皮细胞的功能和完整性来保护预防急性肺损伤. 恢复miR-1水平为肺损伤和急性呼吸困扰综合征提供了潜在的治疗策略.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 内皮细胞生物学 内皮细胞生物学
背景情况:
- 急性肺损伤 (ALI) 和急性呼吸困难综合征 (ARDS) 涉及严重的肺内皮功能障碍.
- 血管内皮生长因子 (VEGF) 在ARDS中升高,表明它参与了损伤过程.
研究的目的:
- 研究微RNA-1 (miR-1) 在肺内皮细胞对急性损伤的反应中的作用.
- 确定miR-1是否具有保护作用,并在ALI/ARDS的背景下确定其目标.
主要方法:
- 在小鼠和人类模型中,肺内皮细胞特异性的miR-1过度表达.
- 在诱导ALI后评估细胞死亡,屏障功能和存活率.
- 基因表达分析和RNA诱导沉默复合体 (RISC) 招募试验以确定miR-1目标.
- 在内皮细胞中验证miR-1标和患者队列中的相关性.
主要成果:
- 在急性损伤后,肺内皮中观察到降低的miR-1水平.
- 过度表达miR-1可以防止内皮细胞死亡,屏障功能障碍和毛细血管泄漏.
- miR-1 抑制了亡和亡途径,并保护了内皮结.
- 确定并验证了PDE5A,ANGPT2,CNKSR3和TNFAIP2作为miR-1目标.
- 在肺炎患者队列中,miR-1和ANGPT2水平之间的反相关性.
结论:
- 在急性肺损伤期间,miR-1在内皮细胞中起着至关重要的细胞保护作用.
- miR-1 作为内皮对损伤反应的协调者,影响细胞生存和屏障完整性.
- miR-1显示出对ALI和ARDS的显著预后和治疗潜力.
更多相关视频
07:05Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
Published on: September 27, 2024
489
14:48Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
5.2K
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:29Acute Respiratory Failure-V
155
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
155